1.	Phase III Randomized Pilot Study of GM-CSF Alone vs G-CSF Alone vs GM-CSF/G-CSF vs PIXY321 for Mobilization of PBSC in Cancer Patients Undergoing Autologous Bone Marrow Transplantation (Summary Last Modified 10/94) Phase: Phase III Type: Treatment Status: Completed Age: over 18 to under 65 Sponsor: NCI Protocol IDs: URCC-6492H, NCI-T92-0010D, T92-0010
2.	Phase III Randomized Study of GM-CSF vs PIXY321 in Patients with Advanced Breast Cancer Receiving FLAC (5-FU/CF/DOX/CTX) Followed by 5 Courses of Continuous-Infusion TAX without Growth Factors (Summary Last Modified 05/94) Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-93-C-0153I, NCI-MB-318, NCI-T93-0041N, T93-0041
3.	Phase I/II Study of PIXY321 (GM-CSF/IL-3 S. cerevisiae Fusion Protein) in Combination with CTX/CBDCA in Patients with Advanced Epithelial Ovarian Cancer Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 to 70 Sponsor: Protocol IDs: AECM-9202054, NCI-V92-0080
4.	Phase I Study of IL-3/GM-CSF Fusion Protein (PIXY321) and CBDCA in Patients with Advanced Cancer (Summary Last Modified 03/94) Phase: Phase I Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: BRMP-9108A, NCI-92-C-0079A, NCI-T91-0213N, T91-0213
5.	Phase I Study of PIXY321 Following ICE (IFF/CBDCA/VP-16) in Children with Recurrent Solid Tumors Phase: Phase I Type: Treatment Status: Closed Age: 1 to 21 at entry Sponsor: NCI Protocol IDs: CCG-0924